[ASND] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[ASND] Ascendis Pharma A/S
Announcement Date
02-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -32.00%
YoY- 23.68%
Quarter Report
ASND's Result
ASND's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 15,290 6,160 6,828 4,897 1,113 1,022 746 647.56%
PBT -169,122 -81,366 -125,257 -106,176 -80,343 -134,442 -62,983 93.07%
Tax -167 -47 241 -114 5 -68 -191 -8.55%
NP -168,955 -81,319 -125,498 -106,062 -80,348 -134,374 -62,792 93.33%
Tax Rate - - - - - - - -
Total Cost 184,245 87,479 132,326 110,959 81,461 135,396 63,538 103.21%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -1,105.00 -1,320.11 -1,837.99 -2,165.86 -7,219.05 -13,148.14 -8,417.16 -74.13%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -3.03 -1.46 -2.21 -1.97 -1.47 -2.50 -1.17 88.47%
EPS Diluted -3.03 -1.46 -2.21 -1.97 -1.47 -2.50 -1.17 88.47%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.